Amp Capital Investors LTD Concert Pharmaceuticals, Inc. Transaction History

Amp Capital Investors LTD

  • $0
  • Q4 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$9.48 - $12.84 $128,928 - $174,624
-13,600 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$8.67 - $10.82 $117,912 - $147,152
13,600 New
13,600 $131,000

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Amp Capital Investors LTD Portfolio

Follow Amp Capital Investors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email